Share Club

2 followers0 views

Watching

9

CompanyPrice & Valuation
FV & Narrative
Valuation
Growth
Analyst Target

GANX

Gain Therapeutics

US$1.84n/aintrinsic discount
9.5%7D
-9.8%3M

The author hasn't set a fair value for GANX

AMTM

Amentum Holdings

US$20.98n/aintrinsic discount
2.4%7D
-24.5%3M

The author hasn't set a fair value for AMTM

FBR

FBR

AU$0.13n/aintrinsic discount
-13.3%7D
-25.7%3M

The author hasn't set a fair value for FBR